OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
6817$61.7054

Winston Medical Supply Co Ltd

PharmaceuticalsVerified

Winston Medical Supply Co Ltd has a market capitalization of TWD 1,136,328,900, with a market price of TWD 61.7 per share. The company has 18,417,000 basic and diluted shares outstanding, indicating no immediate dilution pressure from share issuance. Profitability and return metrics are not available for Winston Medical Supply Co Ltd due to the absence of balance-sheet inputs and relevant financial disclosures in the source documents. As a result, it is not possible to compare the company's performance against industry benchmarks or cohort medians. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the diversification of its revenue streams or the extent of its international operations. Growth trajectory data is limited, as the outlook for the current and next fiscal years is not provided. Historical revenue data is also not available, making it difficult to assess the company's growth momentum or future potential. Risk factors include the inability to assess liquidity risk due to the absence of balance-sheet inputs and no going-concern language in the source documents. The company is currently rated as having low dilution risk, with no immediate pressure from share issuance or capital-raising activities. Recent events, including filings and transcripts, are not disclosed in the available data. As a result, there is no information on recent corporate actions, management commentary, or strategic developments that could impact the company's performance.

30-day price · 6817-5.90 (-8.1%)
Low$64.30High$73.60Close$66.50As of15 May, 00:00 UTC
Profile
CompanyWinston Medical Supply Co Ltd
Ticker6817.TWO
SectorHealthcare
BusinessPharmaceuticals & Medical Research
Industry groupPharmaceuticals & Medical Research
IndustryPharmaceuticals
AI analysis

Business. Winston Medical Supply Co Ltd operates in the pharmaceuticals industry, providing medical supplies and related products to healthcare providers and institutions.

Classification. Winston Medical Supply Co Ltd is classified under the Healthcare economic sector, within the Pharmaceuticals & Medical Research business sector, and the Pharmaceuticals industry, with a confidence level of 0.92.

Winston Medical Supply Co Ltd has a market capitalization of TWD 1,136,328,900, with a market price of TWD 61.7 per share. The company has 18,417,000 basic and diluted shares outstanding, indicating no immediate dilution pressure from share issuance. Profitability and return metrics are not available for Winston Medical Supply Co Ltd due to the absence of balance-sheet inputs and relevant financial disclosures in the source documents. As a result, it is not possible to compare the company's performance against industry benchmarks or cohort medians. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the diversification of its revenue streams or the extent of its international operations. Growth trajectory data is limited, as the outlook for the current and next fiscal years is not provided. Historical revenue data is also not available, making it difficult to assess the company's growth momentum or future potential. Risk factors include the inability to assess liquidity risk due to the absence of balance-sheet inputs and no going-concern language in the source documents. The company is currently rated as having low dilution risk, with no immediate pressure from share issuance or capital-raising activities. Recent events, including filings and transcripts, are not disclosed in the available data. As a result, there is no information on recent corporate actions, management commentary, or strategic developments that could impact the company's performance.
Key takeaways
  • Winston Medical Supply Co Ltd has a market capitalization of TWD 1,136,328,900 and a market price of TWD 61.7 per share.
  • The company has 18,417,000 basic and diluted shares outstanding, indicating no immediate dilution pressure.
  • Profitability and return metrics are not available due to the absence of balance-sheet inputs and relevant financial disclosures.
  • Revenue concentration and geographic exposure are not disclosed, limiting the ability to assess diversification.
  • Growth trajectory and historical revenue data are not available, making it difficult to assess future potential.
  • Liquidity risk cannot be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$536.5M$115.3M$92.1M$67.9M
FY-3$606.5M$135.9M$111.3M$67.3M
FY-2$709.1M$196.1M$158.8M$74.6M
FY-1$695.1M$159.3M$131.6M$20.4M
FY0$700.1M$141.8M$117.3M-$2.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$636.4M$325.3M$162.8M
FY-3$701.4M$361.7M$202.7M
FY-2$801.8M$427.9M$299.1M
FY-1$812.7M$439.4M$299.6M
FY0$780.9M$427.6M$298.9M
PeriodOCFCapExFCFSBC
FY-4$146.5M-$5.1M$67.9M
FY-3$124.9M-$6.6M$67.3M
FY-2$215.4M-$20.0M$74.6M
FY-1$148.1M-$19.3M$20.4M
FY0$155.0M-$17.3M-$2.1M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price$61.70
Market cap$1.14B
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Pharmaceuticals & Medical Research · cohort 693 companies
Metric6817Activity
Op margin2.4% medp25 -91.8% · p75 12.5%
Net margin1.2% medp25 -98.4% · p75 10.4%
Gross margin45.6% medp25 29.8% · p75 66.7%
CapEx / revenue-5.2% medp25 -15.8% · p75 -1.7%
Debt / equity9.3% medp25 0.1% · p75 43.8%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-09 09:10 UTC#3cf6f4bf
Market quoteclose TWD 69.00 · shares 0.02B diluted
no public URL
2026-05-03 07:17 UTC#232526f1
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 02:15 UTCJob: 761a34c9